Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

DIAGNOS Inc. (ADK.V)

TSXV - TSXV Real Time Price. Currency in CAD
0.5300-0.0100 (-1.85%)
At close: 02:37PM EDT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.5400
Open0.5300
Bid0.5300 x 0
Ask0.5400 x 0
Day's Range0.5100 - 0.5300
52 Week Range0.1500 - 0.5900
Volume58,150
Avg. Volume134,891
Market Cap37.954M
Beta (5Y Monthly)-0.07
PE Ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings DateNov 27, 2023 - Dec 01, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ADK.V

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      DIAGNOS Announces Closing of Private Placement and Exercise of Stock Warrants

      BROSSARD, Quebec, May 18, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a Canadian corporation active in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the closing, today, of a non-brokered private placement (“Private Placement”) of unsecured convertible debentures (each a “Debenture”) and stock warrants (each a “Warrant”) for gross proceeds of $865,000.

    • GlobeNewswire

      DIAGNOS and IRIS, The Visual Group strengthen partnership with the launch of “IRIS-ai powered by DIAGNOS”

      IRIS-ai powered by DIAGNOS IRIS-ai powered by DIAGNOS BROSSARD, Quebec, May 17, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the launch of “IRIS-ai powered by DIAGNOS” by IRIS, The Visual Group, in partnership with DIAGNOS. For over two years, IRIS and DIAGNOS have joined forces

    • GlobeNewswire

      DIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of Contexts

      Diagnos - Domain Adaptation Method Diagnos - Domain Adaptation Method BROSSARD, Quebec, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) is one of the leaders in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI). DIAGNOS and École de Technologie Supérieure (ÉTS), a world-renowned technical university, are proud to announce the unveiling of a method for adapt

    Advertisement
    Advertisement